These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7791879)

  • 1. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; Sigmund K; Bangham CR
    Nature; 1995 Jun; 375(6532):606-11. PubMed ID: 7791879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against multiple epitopes.
    Nowak MA; May RM; Sigmund K
    J Theor Biol; 1995 Aug; 175(3):325-53. PubMed ID: 7475080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
    APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity.
    Meyerhans A; Dadaglio G; Vartanian JP; Langlade-Demoyen P; Frank R; Asjö B; Plata F; Wain-Hobson S
    Eur J Immunol; 1991 Oct; 21(10):2637-40. PubMed ID: 1717289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
    Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
    Kawashima Y; Satoh M; Oka S; Shirasaka T; Takiguchi M
    Biochem Biophys Res Commun; 2008 Feb; 366(3):612-6. PubMed ID: 18035044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
    Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
    J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition.
    Rowland-Jones SL; Phillips RE; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; Bangham CR; Rizza CR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1353-4. PubMed ID: 1466955
    [No Abstract]   [Full Text] [Related]  

  • 15. Escape of human immunodeficiency virus from immune control.
    McMichael AJ; Phillips RE
    Annu Rev Immunol; 1997; 15():271-96. PubMed ID: 9143689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
    Wagner R; Leschonsky B; Harrer E; Paulus C; Weber C; Walker BD; Buchbinder S; Wolf H; Kalden JR; Harrer T
    J Immunol; 1999 Mar; 162(6):3727-34. PubMed ID: 10092836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.
    McAdam S; Klenerman P; Tussey L; Rowland-Jones S; Lalloo D; Phillips R; Edwards A; Giangrande P; Brown AL; Gotch F
    J Immunol; 1995 Sep; 155(5):2729-36. PubMed ID: 7544382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
    Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
    Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.